Chemotherapy Plus IM-862 in Treating Patients With Metastatic Colorectal Cancer
Status:
Terminated
Trial end date:
2001-11-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. IM-862 may stop the growth of colorectal cancer by stopping blood
flow to the tumor. It is not yet known if chemotherapy is more effective with or without
IM-862 in treating colorectal cancer.
PURPOSE: Randomized phase II trial to study the effectiveness of chemotherapy plus IM-862 in
treating patients who have metastatic colorectal cancer.